[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Bifidobacteria Probiotic Market Growth 2023-2029

February 2023 | 109 pages | ID: G6A9258D9AA4EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Bifidobacteria are a group of bacteria called probiotics that normally live in your intestines and stomach. They help your body perform essential functions such as digestion and staving off harmful bacteria.

LPI (LP Information)' newest research report, the “Bifidobacteria Probiotic Industry Forecast” looks at past sales and reviews total world Bifidobacteria Probiotic sales in 2022, providing a comprehensive analysis by region and market sector of projected Bifidobacteria Probiotic sales for 2023 through 2029. With Bifidobacteria Probiotic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bifidobacteria Probiotic industry.

This Insight Report provides a comprehensive analysis of the global Bifidobacteria Probiotic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bifidobacteria Probiotic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bifidobacteria Probiotic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bifidobacteria Probiotic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bifidobacteria Probiotic.

The global Bifidobacteria Probiotic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Bifidobacteria Probiotic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Bifidobacteria Probiotic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Bifidobacteria Probiotic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Bifidobacteria Probiotic players cover Chr. Hansen Holding A/S, BioGaia AB, Probi AB, DowDuPont Inc., Nestl? S.A., Procter & Gamble Company, Probiotics International Limite, Lallemand Inc and PharmaCare Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Bifidobacteria Probiotic market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Dry
  • Liquid
Segmentation by application
  • Hypermarket/Supermarket
  • Medical Stores
  • Specialty Stores
  • Online Stores
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Chr. Hansen Holding A/S
  • BioGaia AB
  • Probi AB
  • DowDuPont Inc.
  • Nestl? S.A.
  • Procter & Gamble Company
  • Probiotics International Limite
  • Lallemand Inc
  • PharmaCare Laboratories
  • Dr. Willmar Schwabe Group
  • SymbioPharm GmbH
  • Pfizer
  • Incal Health
Key Questions Addressed in this Report

What is the 10-year outlook for the global Bifidobacteria Probiotic market?

What factors are driving Bifidobacteria Probiotic market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bifidobacteria Probiotic market opportunities vary by end market size?

How does Bifidobacteria Probiotic break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bifidobacteria Probiotic Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Bifidobacteria Probiotic by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Bifidobacteria Probiotic by Country/Region, 2018, 2022 & 2029
2.2 Bifidobacteria Probiotic Segment by Type
  2.2.1 Dry
  2.2.2 Liquid
2.3 Bifidobacteria Probiotic Sales by Type
  2.3.1 Global Bifidobacteria Probiotic Sales Market Share by Type (2018-2023)
  2.3.2 Global Bifidobacteria Probiotic Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Bifidobacteria Probiotic Sale Price by Type (2018-2023)
2.4 Bifidobacteria Probiotic Segment by Application
  2.4.1 Hypermarket/Supermarket
  2.4.2 Medical Stores
  2.4.3 Specialty Stores
  2.4.4 Online Stores
2.5 Bifidobacteria Probiotic Sales by Application
  2.5.1 Global Bifidobacteria Probiotic Sale Market Share by Application (2018-2023)
  2.5.2 Global Bifidobacteria Probiotic Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Bifidobacteria Probiotic Sale Price by Application (2018-2023)

3 GLOBAL BIFIDOBACTERIA PROBIOTIC BY COMPANY

3.1 Global Bifidobacteria Probiotic Breakdown Data by Company
  3.1.1 Global Bifidobacteria Probiotic Annual Sales by Company (2018-2023)
  3.1.2 Global Bifidobacteria Probiotic Sales Market Share by Company (2018-2023)
3.2 Global Bifidobacteria Probiotic Annual Revenue by Company (2018-2023)
  3.2.1 Global Bifidobacteria Probiotic Revenue by Company (2018-2023)
  3.2.2 Global Bifidobacteria Probiotic Revenue Market Share by Company (2018-2023)
3.3 Global Bifidobacteria Probiotic Sale Price by Company
3.4 Key Manufacturers Bifidobacteria Probiotic Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Bifidobacteria Probiotic Product Location Distribution
  3.4.2 Players Bifidobacteria Probiotic Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR BIFIDOBACTERIA PROBIOTIC BY GEOGRAPHIC REGION

4.1 World Historic Bifidobacteria Probiotic Market Size by Geographic Region (2018-2023)
  4.1.1 Global Bifidobacteria Probiotic Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Bifidobacteria Probiotic Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bifidobacteria Probiotic Market Size by Country/Region (2018-2023)
  4.2.1 Global Bifidobacteria Probiotic Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Bifidobacteria Probiotic Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bifidobacteria Probiotic Sales Growth
4.4 APAC Bifidobacteria Probiotic Sales Growth
4.5 Europe Bifidobacteria Probiotic Sales Growth
4.6 Middle East & Africa Bifidobacteria Probiotic Sales Growth

5 AMERICAS

5.1 Americas Bifidobacteria Probiotic Sales by Country
  5.1.1 Americas Bifidobacteria Probiotic Sales by Country (2018-2023)
  5.1.2 Americas Bifidobacteria Probiotic Revenue by Country (2018-2023)
5.2 Americas Bifidobacteria Probiotic Sales by Type
5.3 Americas Bifidobacteria Probiotic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bifidobacteria Probiotic Sales by Region
  6.1.1 APAC Bifidobacteria Probiotic Sales by Region (2018-2023)
  6.1.2 APAC Bifidobacteria Probiotic Revenue by Region (2018-2023)
6.2 APAC Bifidobacteria Probiotic Sales by Type
6.3 APAC Bifidobacteria Probiotic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Bifidobacteria Probiotic by Country
  7.1.1 Europe Bifidobacteria Probiotic Sales by Country (2018-2023)
  7.1.2 Europe Bifidobacteria Probiotic Revenue by Country (2018-2023)
7.2 Europe Bifidobacteria Probiotic Sales by Type
7.3 Europe Bifidobacteria Probiotic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bifidobacteria Probiotic by Country
  8.1.1 Middle East & Africa Bifidobacteria Probiotic Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Bifidobacteria Probiotic Revenue by Country (2018-2023)
8.2 Middle East & Africa Bifidobacteria Probiotic Sales by Type
8.3 Middle East & Africa Bifidobacteria Probiotic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bifidobacteria Probiotic
10.3 Manufacturing Process Analysis of Bifidobacteria Probiotic
10.4 Industry Chain Structure of Bifidobacteria Probiotic

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Bifidobacteria Probiotic Distributors
11.3 Bifidobacteria Probiotic Customer

12 WORLD FORECAST REVIEW FOR BIFIDOBACTERIA PROBIOTIC BY GEOGRAPHIC REGION

12.1 Global Bifidobacteria Probiotic Market Size Forecast by Region
  12.1.1 Global Bifidobacteria Probiotic Forecast by Region (2024-2029)
  12.1.2 Global Bifidobacteria Probiotic Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bifidobacteria Probiotic Forecast by Type
12.7 Global Bifidobacteria Probiotic Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Chr. Hansen Holding A/S
  13.1.1 Chr. Hansen Holding A/S Company Information
  13.1.2 Chr. Hansen Holding A/S Bifidobacteria Probiotic Product Portfolios and Specifications
  13.1.3 Chr. Hansen Holding A/S Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Chr. Hansen Holding A/S Main Business Overview
  13.1.5 Chr. Hansen Holding A/S Latest Developments
13.2 BioGaia AB
  13.2.1 BioGaia AB Company Information
  13.2.2 BioGaia AB Bifidobacteria Probiotic Product Portfolios and Specifications
  13.2.3 BioGaia AB Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 BioGaia AB Main Business Overview
  13.2.5 BioGaia AB Latest Developments
13.3 Probi AB
  13.3.1 Probi AB Company Information
  13.3.2 Probi AB Bifidobacteria Probiotic Product Portfolios and Specifications
  13.3.3 Probi AB Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Probi AB Main Business Overview
  13.3.5 Probi AB Latest Developments
13.4 DowDuPont Inc.
  13.4.1 DowDuPont Inc. Company Information
  13.4.2 DowDuPont Inc. Bifidobacteria Probiotic Product Portfolios and Specifications
  13.4.3 DowDuPont Inc. Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 DowDuPont Inc. Main Business Overview
  13.4.5 DowDuPont Inc. Latest Developments
13.5 Nestl? S.A.
  13.5.1 Nestl? S.A. Company Information
  13.5.2 Nestl? S.A. Bifidobacteria Probiotic Product Portfolios and Specifications
  13.5.3 Nestl? S.A. Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Nestl? S.A. Main Business Overview
  13.5.5 Nestl? S.A. Latest Developments
13.6 Procter & Gamble Company
  13.6.1 Procter & Gamble Company Company Information
  13.6.2 Procter & Gamble Company Bifidobacteria Probiotic Product Portfolios and Specifications
  13.6.3 Procter & Gamble Company Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Procter & Gamble Company Main Business Overview
  13.6.5 Procter & Gamble Company Latest Developments
13.7 Probiotics International Limite
  13.7.1 Probiotics International Limite Company Information
  13.7.2 Probiotics International Limite Bifidobacteria Probiotic Product Portfolios and Specifications
  13.7.3 Probiotics International Limite Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Probiotics International Limite Main Business Overview
  13.7.5 Probiotics International Limite Latest Developments
13.8 Lallemand Inc
  13.8.1 Lallemand Inc Company Information
  13.8.2 Lallemand Inc Bifidobacteria Probiotic Product Portfolios and Specifications
  13.8.3 Lallemand Inc Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Lallemand Inc Main Business Overview
  13.8.5 Lallemand Inc Latest Developments
13.9 PharmaCare Laboratories
  13.9.1 PharmaCare Laboratories Company Information
  13.9.2 PharmaCare Laboratories Bifidobacteria Probiotic Product Portfolios and Specifications
  13.9.3 PharmaCare Laboratories Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 PharmaCare Laboratories Main Business Overview
  13.9.5 PharmaCare Laboratories Latest Developments
13.10 Dr. Willmar Schwabe Group
  13.10.1 Dr. Willmar Schwabe Group Company Information
  13.10.2 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Product Portfolios and Specifications
  13.10.3 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Dr. Willmar Schwabe Group Main Business Overview
  13.10.5 Dr. Willmar Schwabe Group Latest Developments
13.11 SymbioPharm GmbH
  13.11.1 SymbioPharm GmbH Company Information
  13.11.2 SymbioPharm GmbH Bifidobacteria Probiotic Product Portfolios and Specifications
  13.11.3 SymbioPharm GmbH Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 SymbioPharm GmbH Main Business Overview
  13.11.5 SymbioPharm GmbH Latest Developments
13.12 Pfizer
  13.12.1 Pfizer Company Information
  13.12.2 Pfizer Bifidobacteria Probiotic Product Portfolios and Specifications
  13.12.3 Pfizer Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Pfizer Main Business Overview
  13.12.5 Pfizer Latest Developments
13.13 Incal Health
  13.13.1 Incal Health Company Information
  13.13.2 Incal Health Bifidobacteria Probiotic Product Portfolios and Specifications
  13.13.3 Incal Health Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Incal Health Main Business Overview
  13.13.5 Incal Health Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Bifidobacteria Probiotic Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bifidobacteria Probiotic Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Dry
Table 4. Major Players of Liquid
Table 5. Global Bifidobacteria Probiotic Sales by Type (2018-2023) & (K Units)
Table 6. Global Bifidobacteria Probiotic Sales Market Share by Type (2018-2023)
Table 7. Global Bifidobacteria Probiotic Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bifidobacteria Probiotic Revenue Market Share by Type (2018-2023)
Table 9. Global Bifidobacteria Probiotic Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Bifidobacteria Probiotic Sales by Application (2018-2023) & (K Units)
Table 11. Global Bifidobacteria Probiotic Sales Market Share by Application (2018-2023)
Table 12. Global Bifidobacteria Probiotic Revenue by Application (2018-2023)
Table 13. Global Bifidobacteria Probiotic Revenue Market Share by Application (2018-2023)
Table 14. Global Bifidobacteria Probiotic Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Bifidobacteria Probiotic Sales by Company (2018-2023) & (K Units)
Table 16. Global Bifidobacteria Probiotic Sales Market Share by Company (2018-2023)
Table 17. Global Bifidobacteria Probiotic Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bifidobacteria Probiotic Revenue Market Share by Company (2018-2023)
Table 19. Global Bifidobacteria Probiotic Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Bifidobacteria Probiotic Producing Area Distribution and Sales Area
Table 21. Players Bifidobacteria Probiotic Products Offered
Table 22. Bifidobacteria Probiotic Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bifidobacteria Probiotic Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Bifidobacteria Probiotic Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bifidobacteria Probiotic Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bifidobacteria Probiotic Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bifidobacteria Probiotic Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Bifidobacteria Probiotic Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bifidobacteria Probiotic Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bifidobacteria Probiotic Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bifidobacteria Probiotic Sales by Country (2018-2023) & (K Units)
Table 34. Americas Bifidobacteria Probiotic Sales Market Share by Country (2018-2023)
Table 35. Americas Bifidobacteria Probiotic Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bifidobacteria Probiotic Revenue Market Share by Country (2018-2023)
Table 37. Americas Bifidobacteria Probiotic Sales by Type (2018-2023) & (K Units)
Table 38. Americas Bifidobacteria Probiotic Sales by Application (2018-2023) & (K Units)
Table 39. APAC Bifidobacteria Probiotic Sales by Region (2018-2023) & (K Units)
Table 40. APAC Bifidobacteria Probiotic Sales Market Share by Region (2018-2023)
Table 41. APAC Bifidobacteria Probiotic Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bifidobacteria Probiotic Revenue Market Share by Region (2018-2023)
Table 43. APAC Bifidobacteria Probiotic Sales by Type (2018-2023) & (K Units)
Table 44. APAC Bifidobacteria Probiotic Sales by Application (2018-2023) & (K Units)
Table 45. Europe Bifidobacteria Probiotic Sales by Country (2018-2023) & (K Units)
Table 46. Europe Bifidobacteria Probiotic Sales Market Share by Country (2018-2023)
Table 47. Europe Bifidobacteria Probiotic Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bifidobacteria Probiotic Revenue Market Share by Country (2018-2023)
Table 49. Europe Bifidobacteria Probiotic Sales by Type (2018-2023) & (K Units)
Table 50. Europe Bifidobacteria Probiotic Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Bifidobacteria Probiotic Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Bifidobacteria Probiotic Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bifidobacteria Probiotic Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bifidobacteria Probiotic Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bifidobacteria Probiotic Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Bifidobacteria Probiotic Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Bifidobacteria Probiotic
Table 58. Key Market Challenges & Risks of Bifidobacteria Probiotic
Table 59. Key Industry Trends of Bifidobacteria Probiotic
Table 60. Bifidobacteria Probiotic Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bifidobacteria Probiotic Distributors List
Table 63. Bifidobacteria Probiotic Customer List
Table 64. Global Bifidobacteria Probiotic Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Bifidobacteria Probiotic Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bifidobacteria Probiotic Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Bifidobacteria Probiotic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bifidobacteria Probiotic Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Bifidobacteria Probiotic Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bifidobacteria Probiotic Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Bifidobacteria Probiotic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bifidobacteria Probiotic Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Bifidobacteria Probiotic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bifidobacteria Probiotic Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Bifidobacteria Probiotic Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bifidobacteria Probiotic Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Bifidobacteria Probiotic Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Chr. Hansen Holding A/S Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 79. Chr. Hansen Holding A/S Bifidobacteria Probiotic Product Portfolios and Specifications
Table 80. Chr. Hansen Holding A/S Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Chr. Hansen Holding A/S Main Business
Table 82. Chr. Hansen Holding A/S Latest Developments
Table 83. BioGaia AB Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 84. BioGaia AB Bifidobacteria Probiotic Product Portfolios and Specifications
Table 85. BioGaia AB Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. BioGaia AB Main Business
Table 87. BioGaia AB Latest Developments
Table 88. Probi AB Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 89. Probi AB Bifidobacteria Probiotic Product Portfolios and Specifications
Table 90. Probi AB Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Probi AB Main Business
Table 92. Probi AB Latest Developments
Table 93. DowDuPont Inc. Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 94. DowDuPont Inc. Bifidobacteria Probiotic Product Portfolios and Specifications
Table 95. DowDuPont Inc. Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. DowDuPont Inc. Main Business
Table 97. DowDuPont Inc. Latest Developments
Table 98. Nestl? S.A. Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 99. Nestl? S.A. Bifidobacteria Probiotic Product Portfolios and Specifications
Table 100. Nestl? S.A. Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Nestl? S.A. Main Business
Table 102. Nestl? S.A. Latest Developments
Table 103. Procter & Gamble Company Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 104. Procter & Gamble Company Bifidobacteria Probiotic Product Portfolios and Specifications
Table 105. Procter & Gamble Company Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Procter & Gamble Company Main Business
Table 107. Procter & Gamble Company Latest Developments
Table 108. Probiotics International Limite Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 109. Probiotics International Limite Bifidobacteria Probiotic Product Portfolios and Specifications
Table 110. Probiotics International Limite Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Probiotics International Limite Main Business
Table 112. Probiotics International Limite Latest Developments
Table 113. Lallemand Inc Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 114. Lallemand Inc Bifidobacteria Probiotic Product Portfolios and Specifications
Table 115. Lallemand Inc Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Lallemand Inc Main Business
Table 117. Lallemand Inc Latest Developments
Table 118. PharmaCare Laboratories Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 119. PharmaCare Laboratories Bifidobacteria Probiotic Product Portfolios and Specifications
Table 120. PharmaCare Laboratories Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. PharmaCare Laboratories Main Business
Table 122. PharmaCare Laboratories Latest Developments
Table 123. Dr. Willmar Schwabe Group Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 124. Dr. Willmar Schwabe Group Bifidobacteria Probiotic Product Portfolios and Specifications
Table 125. Dr. Willmar Schwabe Group Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Dr. Willmar Schwabe Group Main Business
Table 127. Dr. Willmar Schwabe Group Latest Developments
Table 128. SymbioPharm GmbH Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 129. SymbioPharm GmbH Bifidobacteria Probiotic Product Portfolios and Specifications
Table 130. SymbioPharm GmbH Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. SymbioPharm GmbH Main Business
Table 132. SymbioPharm GmbH Latest Developments
Table 133. Pfizer Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 134. Pfizer Bifidobacteria Probiotic Product Portfolios and Specifications
Table 135. Pfizer Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Pfizer Main Business
Table 137. Pfizer Latest Developments
Table 138. Incal Health Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 139. Incal Health Bifidobacteria Probiotic Product Portfolios and Specifications
Table 140. Incal Health Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Incal Health Main Business
Table 142. Incal Health Latest Developments

LIST OF FIGURES

Figure 1. Picture of Bifidobacteria Probiotic
Figure 2. Bifidobacteria Probiotic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bifidobacteria Probiotic Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Bifidobacteria Probiotic Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bifidobacteria Probiotic Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Dry
Figure 10. Product Picture of Liquid
Figure 11. Global Bifidobacteria Probiotic Sales Market Share by Type in 2022
Figure 12. Global Bifidobacteria Probiotic Revenue Market Share by Type (2018-2023)
Figure 13. Bifidobacteria Probiotic Consumed in Hypermarket/Supermarket
Figure 14. Global Bifidobacteria Probiotic Market: Hypermarket/Supermarket (2018-2023) & (K Units)
Figure 15. Bifidobacteria Probiotic Consumed in Medical Stores
Figure 16. Global Bifidobacteria Probiotic Market: Medical Stores (2018-2023) & (K Units)
Figure 17. Bifidobacteria Probiotic Consumed in Specialty Stores
Figure 18. Global Bifidobacteria Probiotic Market: Specialty Stores (2018-2023) & (K Units)
Figure 19. Bifidobacteria Probiotic Consumed in Online Stores
Figure 20. Global Bifidobacteria Probiotic Market: Online Stores (2018-2023) & (K Units)
Figure 21. Global Bifidobacteria Probiotic Sales Market Share by Application (2022)
Figure 22. Global Bifidobacteria Probiotic Revenue Market Share by Application in 2022
Figure 23. Bifidobacteria Probiotic Sales Market by Company in 2022 (K Units)
Figure 24. Global Bifidobacteria Probiotic Sales Market Share by Company in 2022
Figure 25. Bifidobacteria Probiotic Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Bifidobacteria Probiotic Revenue Market Share by Company in 2022
Figure 27. Global Bifidobacteria Probiotic Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Bifidobacteria Probiotic Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Bifidobacteria Probiotic Sales 2018-2023 (K Units)
Figure 30. Americas Bifidobacteria Probiotic Revenue 2018-2023 ($ Millions)
Figure 31. APAC Bifidobacteria Probiotic Sales 2018-2023 (K Units)
Figure 32. APAC Bifidobacteria Probiotic Revenue 2018-2023 ($ Millions)
Figure 33. Europe Bifidobacteria Probiotic Sales 2018-2023 (K Units)
Figure 34. Europe Bifidobacteria Probiotic Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Bifidobacteria Probiotic Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Bifidobacteria Probiotic Revenue 2018-2023 ($ Millions)
Figure 37. Americas Bifidobacteria Probiotic Sales Market Share by Country in 2022
Figure 38. Americas Bifidobacteria Probiotic Revenue Market Share by Country in 2022
Figure 39. Americas Bifidobacteria Probiotic Sales Market Share by Type (2018-2023)
Figure 40. Americas Bifidobacteria Probiotic Sales Market Share by Application (2018-2023)
Figure 41. United States Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Bifidobacteria Probiotic Sales Market Share by Region in 2022
Figure 46. APAC Bifidobacteria Probiotic Revenue Market Share by Regions in 2022
Figure 47. APAC Bifidobacteria Probiotic Sales Market Share by Type (2018-2023)
Figure 48. APAC Bifidobacteria Probiotic Sales Market Share by Application (2018-2023)
Figure 49. China Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Bifidobacteria Probiotic Sales Market Share by Country in 2022
Figure 57. Europe Bifidobacteria Probiotic Revenue Market Share by Country in 2022
Figure 58. Europe Bifidobacteria Probiotic Sales Market Share by Type (2018-2023)
Figure 59. Europe Bifidobacteria Probiotic Sales Market Share by Application (2018-2023)
Figure 60. Germany Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Bifidobacteria Probiotic Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Bifidobacteria Probiotic Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Bifidobacteria Probiotic Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Bifidobacteria Probiotic Sales Market Share by Application (2018-2023)
Figure 69. Egypt Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Bifidobacteria Probiotic Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Bifidobacteria Probiotic in 2022
Figure 75. Manufacturing Process Analysis of Bifidobacteria Probiotic
Figure 76. Industry Chain Structure of Bifidobacteria Probiotic
Figure 77. Channels of Distribution
Figure 78. Global Bifidobacteria Probiotic Sales Market Forecast by Region (2024-2029)
Figure 79. Global Bifidobacteria Probiotic Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Bifidobacteria Probiotic Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Bifidobacteria Probiotic Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Bifidobacteria Probiotic Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Bifidobacteria Probiotic Revenue Market Share Forecast by Application (2024-2029)


More Publications